U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710703) titled 'NWRD09 for Persistent Cervical HPV16 Infection' on July 13.
Brief Summary: This is a randomized, double-blind, placebo controlled study to determine the efficacy and safety of NWRD09 in adult women with persistent cervical HPV16 infection.
Study Start Date: Feb. 10
Study Type: INTERVENTIONAL
Condition:
Persistent Cervical HPV16 Infection
Intervention:
BIOLOGICAL: NWRD09/ Placebo administered by IM injection
NWRD09/ Placebo
Recruitment Status: RECRUITING
Sponsor: Newish Biotech (Wuxi) Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....